| Angela Marie Lostritto, DPT | |
|
49 Seekonk St, Providence, RI 02906-5176 | |
| (401) 230-1126 | |
| Not Available |
| Full Name | Angela Marie Lostritto |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 10 Years |
| Location | 49 Seekonk St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023417698 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT02717 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Silver Fern Practice Llc | 1658266515 | 120 |
News Archive
Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove very small breast cancers that can be seen on a mammogram but not felt in the breast.
Disease statistics buried within patient records or detailed in newspaper clippings can be sorted and organized to depict geographic patterns, allowing the discovery of trends that were previously overlooked, according to a Penn State geographer.
Headache is a very common complaint, with over 90% of all persons experiencing a headache at some time in their lives. Headaches commonly are tension-type (TTH) or migraine. They have high socioeconomic impact and can disturb most daily activities. Treatments range from pharmacologic to behavioral interventions.
Scientific Research concludes that waking up to a Lumie Bodyclock can help to beat milder forms of Seasonal Affective Disorder (SAD), otherwise known as the Winter Blues.
Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.
› Verified 1 days ago
| Provider Name | Silver Fern Practice Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1851472914 PECOS PAC ID: 1658266515 Enrollment ID: O20120813000580 |
News Archive
Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove very small breast cancers that can be seen on a mammogram but not felt in the breast.
Disease statistics buried within patient records or detailed in newspaper clippings can be sorted and organized to depict geographic patterns, allowing the discovery of trends that were previously overlooked, according to a Penn State geographer.
Headache is a very common complaint, with over 90% of all persons experiencing a headache at some time in their lives. Headaches commonly are tension-type (TTH) or migraine. They have high socioeconomic impact and can disturb most daily activities. Treatments range from pharmacologic to behavioral interventions.
Scientific Research concludes that waking up to a Lumie Bodyclock can help to beat milder forms of Seasonal Affective Disorder (SAD), otherwise known as the Winter Blues.
Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela Marie Lostritto, DPT 4 Richmond Sq Ste 200, Providence, RI 02906-5117 Ph: (401) 433-4172 | Angela Marie Lostritto, DPT 49 Seekonk St, Providence, RI 02906-5176 Ph: (401) 230-1126 |
News Archive
Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove very small breast cancers that can be seen on a mammogram but not felt in the breast.
Disease statistics buried within patient records or detailed in newspaper clippings can be sorted and organized to depict geographic patterns, allowing the discovery of trends that were previously overlooked, according to a Penn State geographer.
Headache is a very common complaint, with over 90% of all persons experiencing a headache at some time in their lives. Headaches commonly are tension-type (TTH) or migraine. They have high socioeconomic impact and can disturb most daily activities. Treatments range from pharmacologic to behavioral interventions.
Scientific Research concludes that waking up to a Lumie Bodyclock can help to beat milder forms of Seasonal Affective Disorder (SAD), otherwise known as the Winter Blues.
Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.
› Verified 1 days ago
Conor D. Bray, P.T., D.P.T Physical Therapist Medicare: Medicare Enrolled Practice Location: 49 Seekonk St, Providence, RI 02906 Phone: 401-726-7100 | |
Nicholas Ford, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 49 Seekonk St, Providence, RI 02906 Phone: 401-726-7100 | |
Mr. Thomas H. Wheeler, MMSC, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 830 Chalkstone Ave, Providence, RI 02908 Phone: 401-273-7100 | |
Mrs. Erin Kelli Dasilva, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 765 Allens Ave, Providence, RI 02905 Phone: 401-444-5020 Fax: 401-444-4181 | |
Alaina Lynn Denoncour, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 285 Promenade St, Providence, RI 02908 Phone: 401-459-4001 Fax: 401-459-4006 | |
Eileen T Tainsh, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, George Clinic, Providence, RI 02903 Phone: 401-444-3201 Fax: 401-444-6115 |